MyAverix Finance
US · Healthcare
Shenzhen Hepalink Pharmaceutical Group Co. Ltd (SHEZF)
Drug Manufacturers - Specialty & Generic
Shenzhen Hepalink Pharmaceutical Group Co. Ltd (SHEZF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SHEZF
Shenzhen Hepalink Pharmaceutical Group Co. Ltd (SHEZF) — FAQ
What is SHEZF's P/E ratio?
The price-to-earnings (P/E) ratio for Shenzhen Hepalink Pharmaceutical Group Co. Ltd (SHEZF) is 18.00 (data as of 2026-05-23).
Does Shenzhen Hepalink Pharmaceutical Group Co. Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Shenzhen Hepalink Pharmaceutical Group Co. Ltd (SHEZF). Check the MyAverix Finance app for the latest dividend data.
What sector is Shenzhen Hepalink Pharmaceutical Group Co. Ltd in?
Shenzhen Hepalink Pharmaceutical Group Co. Ltd (SHEZF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is SHEZF listed on?
SHEZF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.